Empagliflozin 25mg
$165.00 – $420.00

| Product name | Vildagliptin-Metformin 50mg-850mg |
|---|---|
| Active Ingredient | Vildagliptin-Metformin |
| Dosage | 50mg-850mg |
| Drug Type | Tablets |
| Indication | Type 2 Diabetes |
| Manufacturer | Novartis |
Vildagliptin-Metformin 50mg-850mg Tablets
In stock
Total $61.80
Vildagliptin–Metformin 50mg–850mg tablet is a prescription medicine used to control type 2 diabetes mellitus. Doctors such as a diabetologist or physician prescribe it when blood sugar is not well controlled with diet, exercise, or a single medicine.
This tablet combines vildagliptin 50mg and metformin 850mg. Both medicines lower blood sugar in different ways. The combination gives better and more stable glucose control throughout the day.
Type 2 diabetes is a long-term condition. The body either does not make enough insulin or cannot use insulin properly. This leads to high blood sugar. Over time, high sugar levels can damage the heart, kidneys, eyes, and nerves.
Vildagliptin–Metformin 50mg–850mg controls blood sugar through two actions.
Vildagliptin increases natural hormones called incretins. These hormones help the pancreas release insulin after meals. They also reduce extra sugar production in the liver.
Metformin reduces sugar production in the liver. It also helps the body use insulin better. This improves how cells take in glucose from the blood.
Together, these actions lower both fasting blood sugar and post-meal sugar levels. This helps keep glucose levels steady during the day.
Doctors prescribe Vildagliptin–Metformin tablet for type 2 diabetes treatment. A diabetologist or physician selects the dose based on blood sugar readings and patient response.
It is used when blood sugar is not controlled with a single medicine.
It helps manage fasting and post-meal glucose levels.
It supports better HbA1c control, which reflects long-term blood sugar levels.
It is not used for type 1 diabetes or emergency conditions like diabetic ketoacidosis.
Vildagliptin mechanism of action blocks the DPP-4 enzyme. This increases incretin hormone levels. These hormones boost insulin release when needed and reduce sugar production in the liver.
Metformin mechanism of action lowers glucose production in the liver. It also improves insulin sensitivity in body tissues.
Together, these two medicines act on different pathways. This results in better and more consistent blood sugar control.
Most people tolerate Vildagliptin–Metformin well. Some mild side effects can occur.
Some patients may feel nausea or stomach discomfort, especially at the start of treatment.
Loose stools or mild diarrhea may occur in some individuals.
Some people may experience headache or dizziness.
Occasionally, loss of appetite or weakness may be noticed.
Rarely, low blood sugar (hypoglycemia) can occur, especially if used with other diabetes medicines.
Very rarely, lactic acidosis may occur due to metformin, especially in patients with kidney problems.
Use Vildagliptin–Metformin 50mg–850mg tablet only under the supervision of a diabetologist or physician.
Take the tablet with meals to reduce stomach side effects.
Do not skip doses. Regular use helps maintain stable blood sugar.
Inform your doctor if you have kidney disease, liver problems, or heart conditions.
Regular checks of blood sugar, kidney function, and HbA1c may be required.
Avoid excess alcohol, as it may increase the risk of side effects.
Follow a healthy diet and regular exercise plan for better results.
If prescribed, you can order Vildagliptin–Metformin 50mg–850mg tablets online from trusted pharmacy sources and continue your diabetes treatment safely under medical supervision.
This content is for educational purposes only. It does not replace medical advice. Always consult a qualified healthcare professional such as a diabetologist or physician before starting or stopping Vildagliptin–Metformin 50mg–850mg tablet.